Establishment Labs Holdings (ESTA) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) Property, Plant & Equipment (Net) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 10.07% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 8.57% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 17.92% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.47% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 13.19% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.97% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 191.70% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.68 Bn | 42.34 Mn | 9.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.38% |
| Dec 31, 2025 | 13.96% |
| Sep 30, 2025 | 24.81% |
| Jun 30, 2025 | 29.26% |
| Mar 31, 2025 | 48.56% |
| Dec 31, 2024 | 61.11% |
| Sep 30, 2024 | 67.90% |
| Jun 30, 2024 | 68.63% |
| Mar 31, 2024 | 69.33% |
| Dec 31, 2023 | 68.28% |
| Sep 30, 2023 | 64.69% |
| Mar 31, 2023 | 52.03% |
| Dec 31, 2022 | 46.00% |
| Sep 30, 2022 | 33.05% |
| Jun 30, 2022 | 28.39% |
| Mar 31, 2022 | 20.85% |
| Dec 31, 2021 | 13.05% |
| Sep 30, 2021 | 9.19% |
| Jun 30, 2021 | 7.81% |
| Dec 31, 2020 | 6.27% |